Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2000
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells
B Schuler-Thurner, D Dieckmann, P Keikavoussi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions
H A Haenssle, C Fink, F Toberer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 8, 2018
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1
G M Haag, I Zoernig, J C Hassel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 10, 2016
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)
P Saiag, R Gutzmer, P A Ascierto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2006
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
D Schadendorf, S Ugurel, B Schuler-Thurner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma
K C Kähler, J C Hassel, M Ziemer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 21, 2013
Guidelines on the use of extracorporeal photopheresis
R Knobler, G Berlin, P Calzavara-Pinton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 26, 2020
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force
C Garbe, K Peris, E Soura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2018
Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists
H A Haenssle, C Fink, R Schneiderbauer, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
September 12, 2013
[Phlebology in German departments of dermatology. An analysis on behalf of the German Society of Phlebology]
S Reich-Schupke, J Alm, P Altmeyer, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2000
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells
B Schuler-Thurner, D Dieckmann, P Keikavoussi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions
H A Haenssle, C Fink, F Toberer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 8, 2018
Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1
G M Haag, I Zoernig, J C Hassel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 10, 2016
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT)
P Saiag, R Gutzmer, P A Ascierto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2006
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG
D Schadendorf, S Ugurel, B Schuler-Thurner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma
K C Kähler, J C Hassel, M Ziemer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 21, 2013
Guidelines on the use of extracorporeal photopheresis
R Knobler, G Berlin, P Calzavara-Pinton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 26, 2020
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force
C Garbe, K Peris, E Soura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2018
Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists
H A Haenssle, C Fink, R Schneiderbauer, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
September 12, 2013
[Phlebology in German departments of dermatology. An analysis on behalf of the German Society of Phlebology]
S Reich-Schupke, J Alm, P Altmeyer, et al.
Page
of 6